Neoplasm Micrometastasis

"Neoplasm Micrometastasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Newly arising secondary tumors so small they are difficult to detect by physical examination or routine imaging techniques.

Descriptor ID	D061206
MeSH Number(s)	C04.697.650.695 C23.550.727.650.695
Concept/Terms	Neoplasm Micrometastasis Neoplasm Micrometastasis Neoplasm Micrometastases Micrometastasis, Neoplasm Micrometastases, Neoplasm Micrometastase, Neoplasm Neoplasm Micrometastase Micrometastasis Micrometastases

Below are MeSH descriptors whose meaning is more general than "Neoplasm Micrometastasis".

Diseases [C]
Neoplasms [C04]
Neoplastic Processes [C04.697]
Neoplasm Metastasis [C04.697.650]
Neoplasm Micrometastasis [C04.697.650.695]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Neoplastic Processes [C23.550.727]
Neoplasm Metastasis [C23.550.727.650]
Neoplasm Micrometastasis [C23.550.727.650.695]

Below are MeSH descriptors whose meaning is related to "Neoplasm Micrometastasis".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm Micrometastasis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm Micrometastasis" by people in this website by year, and whether "Neoplasm Micrometastasis" was a major or minor topic of these publications.

Bar chart showing 9 publications over 7 distinct years, with a maximum of 2 publications in 2012 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2012	1	1	2
2014	0	1	1
2015	0	1	1
2017	0	1	1
2018	1	1	2
2019	0	1	1
2021	0	1	1

Below are the most recent publications written about "Neoplasm Micrometastasis" by people in Profiles.

Tsai CF, Zhang P, Scholten D, Martin K, Wang YT, Zhao R, Chrisler WB, Patel DB, Dou M, Jia Y, Reduzzi C, Liu X, Moore RJ, Burnum-Johnson KE, Lin MH, Hsu CC, Jacobs JM, Kagan J, Srivastava S, Rodland KD, Steven Wiley H, Qian WJ, Smith RD, Zhu Y, Cristofanilli M, Liu T, Liu H, Shi T. Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics. Commun Biol. 2021 03 01; 4(1):265.

View in: PubMed
Grabenstetter A, Moo TA, Hajiyeva S, Sch?ffler PJ, Khattar P, Friedlander MA, McCormack MA, Raiss M, Zabor EC, Barrio A, Morrow M, Edelweiss M. Accuracy of Intraoperative Frozen Section of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy for Breast Carcinoma. Am J Surg Pathol. 2019 10; 43(10):1377-1383.

View in: PubMed
Lee SB, Kim J, Sohn G, Kim J, Chung IY, Kim HJ, Ko BS, Son BH, Ahn SH, Lee JW, Jung KH. A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor?Positive, Human Epidermal Growth Factor 2 (HER2)?Negative Breast Cancer. Cancer Res Treat. 2019 Jul; 51(3):1073-1085.

View in: PubMed
Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio A, Morrow M. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Ann Surg Oncol. 2018 Jun; 25(6):1488-1494.

View in: PubMed
Marino IR, Carr BI. New Developments in Orthotopic Liver Transplant for Hepatocellular Carcinoma. Exp Clin Transplant. 2017 Mar; 15(Suppl 2):1-6.

View in: PubMed
Moen I, Gebre M, Alonso-Camino V, Chen D, Epstein D, McDonald DM. Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors. Clin Exp Metastasis. 2015 Dec; 32(8):799-817.

View in: PubMed
Poling JS, Tsangaris TN, Argani P, Cimino-Mathews A. Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases. Breast Cancer Res Treat. 2014 Nov; 148(2):355-61.

View in: PubMed
Schwartz GF, Bartelink H, Burstein HJ, Cady B, Cataliotti L, Fentiman IS, Holland R, Hughes KS, Masood S, McCormick B, Palazzo JA, Pressman PI, Reis-Filho J, Pusztai L, Rutgers EJ, Seidman AD, Solin LJ, Sparano JA. Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping. Breast J. 2012 Jul-Aug; 18(4):303-11.

View in: PubMed
Alsamarai S, Abu-Khalaf MM, Harris LN. DTCs/CTCs in breast cancer: five decades later. Recent Results Cancer Res. 2012; 195:217-25.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement